背景:PANELVIEW是一种用于评估过程适当性的工具,方法,以及指南制定的结果以及指南小组对这些步骤的满意度。
目的:从指南组的角度评估德国严重/多发伤患者治疗指南(“德国多发性创伤指南”)的指南制定过程,并确定将来可能改进此过程的领域。
方法:我们对2022年德国多发性创伤指南更新的参与者进行了PANELVIEW。所有准则组成员,包括参与的医学协会的代表,指导小组成员,指南章节的作者,椅子,和方法论上的领导,被邀请参加。采用描述性统计分析。收到的评论按工具的领域/项目分类。
结果:在第一个结果之后,第二,和最后一次共识会议,指南组通过电子邮件被邀请参加一项基于网络的调查.有效率为36%(n/N=13/36),40%(12/30),和37%(20/54),分别。项目的平均得分在1(完全不同意)到7(完全同意)的范围内的5.1和6.9之间。平均得分低于6.0的项目与(1)管理有关,(2)考虑患者的意见,观点,值,和偏好,(3)讨论了研究差距和未来研究的需求。
结论:PANELVIEW工具显示,指南组对指南制定过程的大部分方面都感到满意。确定了改进该过程的领域。应探索提高答复率的战略。
BACKGROUND: PANELVIEW is an instrument for evaluating the appropriateness of the process, methods, and outcome of guideline development and the satisfaction of the guideline group with these steps.
OBJECTIVE: To evaluate the guideline development process of the German guideline on the treatment of patients with severe/multiple injuries (\'German polytrauma guideline\') from the perspective of the guideline group, and to identify areas where this process may be improved in the future.
METHODS: We administered PANELVIEW to the participants of the 2022 update of the German polytrauma guideline. All guideline group members, including delegates of participating medical societies, steering group members, authors of guideline chapters, the chair, and methodological lead, were invited to participate. Responses were analysed using descriptive statistics. Comments received were categorised by domains/items of the tool.
RESULTS: After the first, second, and last consensus conference, the guideline group was invited via email to participate in a web-based survey. Response rates were 36% (n/N = 13/36), 40% (12/30), and 37% (20/54), respectively. The mean scores for items ranged between 5.1 and 6.9 on a scale from 1 (fully disagree) to 7 (fully agree). Items with mean scores below 6.0 were related to (1) administration, (2) consideration of patients\' views, perspectives, values, and preferences, and (3) the discussion of research gaps and needs for future research.
CONCLUSIONS: The PANELVIEW tool showed that the guideline group was satisfied with most aspects of the guideline development process. Areas for improvement of the process were identified. Strategies to improve response rates should be explored.